Global G-CSF Biosimilars Market Growth 2022-2028
- LP 4924018
- 100 Pages
- March 2022
- Pharmaceuticals
The United States G-CSF Biosimilars market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global G-CSF Biosimilars market, reaching US$ million by the year 2028. As for the Europe G-CSF Biosimilars landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main G-CSF Biosimilars players cover Pfizer, Novartis, Roche, and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of G-CSF Biosimilars market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global G-CSF Biosimilars Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for G-CSF Biosimilars by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for G-CSF Biosimilars by Country/Region, 2017, 2022 & 2028
2.2 G-CSF Biosimilars Segment by Type
2.2.1 Human Growth Hormone
2.2.2 Erythropoietin
2.2.3 Monoclonal Antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.3 G-CSF Biosimilars Sales by Type
2.3.1 Global G-CSF Biosimilars Sales Market Share by Type (2017-2022)
2.3.2 Global G-CSF Biosimilars Revenue and Market Share by Type (2017-2022)
2.3.3 Global G-CSF Biosimilars Sale Price by Type (2017-2022)
2.4 G-CSF Biosimilars Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.4.3 Chronic And Autoimmune Diseases
2.4.4 Growth Hormone Deficiencies
2.5 G-CSF Biosimilars Sales by Application
2.5.1 Global G-CSF Biosimilars Sale Market Share by Application (2017-2022)
2.5.2 Global G-CSF Biosimilars Revenue and Market Share by Application (2017-2022)
2.5.3 Global G-CSF Biosimilars Sale Price by Application (2017-2022)
3 Global G-CSF Biosimilars by Company
3.1 Global G-CSF Biosimilars Breakdown Data by Company
3.1.1 Global G-CSF Biosimilars Annual Sales by Company (2020-2022)
3.1.2 Global G-CSF Biosimilars Sales Market Share by Company (2020-2022)
3.2 Global G-CSF Biosimilars Annual Revenue by Company (2020-2022)
3.2.1 Global G-CSF Biosimilars Revenue by Company (2020-2022)
3.2.2 Global G-CSF Biosimilars Revenue Market Share by Company (2020-2022)
3.3 Global G-CSF Biosimilars Sale Price by Company
3.4 Key Manufacturers G-CSF Biosimilars Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers G-CSF Biosimilars Product Location Distribution
3.4.2 Players G-CSF Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for G-CSF Biosimilars by Geographic Region
4.1 World Historic G-CSF Biosimilars Market Size by Geographic Region (2017-2022)
4.1.1 Global G-CSF Biosimilars Annual Sales by Geographic Region (2017-2022)
4.1.2 Global G-CSF Biosimilars Annual Revenue by Geographic Region
4.2 World Historic G-CSF Biosimilars Market Size by Country/Region (2017-2022)
4.2.1 Global G-CSF Biosimilars Annual Sales by Country/Region (2017-2022)
4.2.2 Global G-CSF Biosimilars Annual Revenue by Country/Region
4.3 Americas G-CSF Biosimilars Sales Growth
4.4 APAC G-CSF Biosimilars Sales Growth
4.5 Europe G-CSF Biosimilars Sales Growth
4.6 Middle East & Africa G-CSF Biosimilars Sales Growth
5 Americas
5.1 Americas G-CSF Biosimilars Sales by Country
5.1.1 Americas G-CSF Biosimilars Sales by Country (2017-2022)
5.1.2 Americas G-CSF Biosimilars Revenue by Country (2017-2022)
5.2 Americas G-CSF Biosimilars Sales by Type
5.3 Americas G-CSF Biosimilars Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC G-CSF Biosimilars Sales by Region
6.1.1 APAC G-CSF Biosimilars Sales by Region (2017-2022)
6.1.2 APAC G-CSF Biosimilars Revenue by Region (2017-2022)
6.2 APAC G-CSF Biosimilars Sales by Type
6.3 APAC G-CSF Biosimilars Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe G-CSF Biosimilars by Country
7.1.1 Europe G-CSF Biosimilars Sales by Country (2017-2022)
7.1.2 Europe G-CSF Biosimilars Revenue by Country (2017-2022)
7.2 Europe G-CSF Biosimilars Sales by Type
7.3 Europe G-CSF Biosimilars Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa G-CSF Biosimilars by Country
8.1.1 Middle East & Africa G-CSF Biosimilars Sales by Country (2017-2022)
8.1.2 Middle East & Africa G-CSF Biosimilars Revenue by Country (2017-2022)
8.2 Middle East & Africa G-CSF Biosimilars Sales by Type
8.3 Middle East & Africa G-CSF Biosimilars Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of G-CSF Biosimilars
10.3 Manufacturing Process Analysis of G-CSF Biosimilars
10.4 Industry Chain Structure of G-CSF Biosimilars
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 G-CSF Biosimilars Distributors
11.3 G-CSF Biosimilars Customer
12 World Forecast Review for G-CSF Biosimilars by Geographic Region
12.1 Global G-CSF Biosimilars Market Size Forecast by Region
12.1.1 Global G-CSF Biosimilars Forecast by Region (2023-2028)
12.1.2 Global G-CSF Biosimilars Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global G-CSF Biosimilars Forecast by Type
12.7 Global G-CSF Biosimilars Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer G-CSF Biosimilars Product Offered
13.1.3 Pfizer G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis G-CSF Biosimilars Product Offered
13.2.3 Novartis G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche G-CSF Biosimilars Product Offered
13.3.3 Roche G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. G-CSF Biosimilars Product Offered
13.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi G-CSF Biosimilars Product Offered
13.5.3 Sanofi G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson G-CSF Biosimilars Product Offered
13.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Gilead Science
13.7.1 Gilead Science Company Information
13.7.2 Gilead Science G-CSF Biosimilars Product Offered
13.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Gilead Science Main Business Overview
13.7.5 Gilead Science Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline G-CSF Biosimilars Product Offered
13.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 AbbVie
13.9.1 AbbVie Company Information
13.9.2 AbbVie G-CSF Biosimilars Product Offered
13.9.3 AbbVie G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AbbVie Main Business Overview
13.9.5 AbbVie Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen G-CSF Biosimilars Product Offered
13.10.3 Amgen G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
13.11 AstraZeneca
13.11.1 AstraZeneca Company Information
13.11.2 AstraZeneca G-CSF Biosimilars Product Offered
13.11.3 AstraZeneca G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Main Business Overview
13.11.5 AstraZeneca Latest Developments
13.12 Bayer
13.12.1 Bayer Company Information
13.12.2 Bayer G-CSF Biosimilars Product Offered
13.12.3 Bayer G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bayer Main Business Overview
13.12.5 Bayer Latest Developments
14 Research Findings and Conclusion
Table 1. G-CSF Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. G-CSF Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Human Growth Hormone
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Insulin
Table 7. Major Players of Interferon
Table 8. Major Players of Granulocyte-Colony Stimulating Factor
Table 9. Global G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 10. Global G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 11. Global G-CSF Biosimilars Revenue by Type (2017-2022) & ($ million)
Table 12. Global G-CSF Biosimilars Revenue Market Share by Type (2017-2022)
Table 13. Global G-CSF Biosimilars Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 15. Global G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 16. Global G-CSF Biosimilars Revenue by Application (2017-2022)
Table 17. Global G-CSF Biosimilars Revenue Market Share by Application (2017-2022)
Table 18. Global G-CSF Biosimilars Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global G-CSF Biosimilars Sales by Company (2020-2022) & (K Units)
Table 20. Global G-CSF Biosimilars Sales Market Share by Company (2020-2022)
Table 21. Global G-CSF Biosimilars Revenue by Company (2020-2022) ($ Millions)
Table 22. Global G-CSF Biosimilars Revenue Market Share by Company (2020-2022)
Table 23. Global G-CSF Biosimilars Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers G-CSF Biosimilars Producing Area Distribution and Sales Area
Table 25. Players G-CSF Biosimilars Products Offered
Table 26. G-CSF Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global G-CSF Biosimilars Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global G-CSF Biosimilars Sales Market Share Geographic Region (2017-2022)
Table 31. Global G-CSF Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global G-CSF Biosimilars Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global G-CSF Biosimilars Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global G-CSF Biosimilars Sales Market Share by Country/Region (2017-2022)
Table 35. Global G-CSF Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global G-CSF Biosimilars Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
Table 38. Americas G-CSF Biosimilars Sales Market Share by Country (2017-2022)
Table 39. Americas G-CSF Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas G-CSF Biosimilars Revenue Market Share by Country (2017-2022)
Table 41. Americas G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 42. Americas G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 43. Americas G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 44. Americas G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 45. APAC G-CSF Biosimilars Sales by Region (2017-2022) & (K Units)
Table 46. APAC G-CSF Biosimilars Sales Market Share by Region (2017-2022)
Table 47. APAC G-CSF Biosimilars Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC G-CSF Biosimilars Revenue Market Share by Region (2017-2022)
Table 49. APAC G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 50. APAC G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 51. APAC G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 52. APAC G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 53. Europe G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
Table 54. Europe G-CSF Biosimilars Sales Market Share by Country (2017-2022)
Table 55. Europe G-CSF Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe G-CSF Biosimilars Revenue Market Share by Country (2017-2022)
Table 57. Europe G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 58. Europe G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 59. Europe G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 60. Europe G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa G-CSF Biosimilars Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa G-CSF Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa G-CSF Biosimilars Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa G-CSF Biosimilars Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of G-CSF Biosimilars
Table 70. Key Market Challenges & Risks of G-CSF Biosimilars
Table 71. Key Industry Trends of G-CSF Biosimilars
Table 72. G-CSF Biosimilars Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. G-CSF Biosimilars Distributors List
Table 75. G-CSF Biosimilars Customer List
Table 76. Global G-CSF Biosimilars Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global G-CSF Biosimilars Sales Market Forecast by Region
Table 78. Global G-CSF Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global G-CSF Biosimilars Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas G-CSF Biosimilars Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas G-CSF Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC G-CSF Biosimilars Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC G-CSF Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe G-CSF Biosimilars Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe G-CSF Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa G-CSF Biosimilars Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa G-CSF Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global G-CSF Biosimilars Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global G-CSF Biosimilars Sales Market Share Forecast by Type (2023-2028)
Table 90. Global G-CSF Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global G-CSF Biosimilars Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global G-CSF Biosimilars Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global G-CSF Biosimilars Sales Market Share Forecast by Application (2023-2028)
Table 94. Global G-CSF Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global G-CSF Biosimilars Revenue Market Share Forecast by Application (2023-2028)
Table 96. Pfizer Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 97. Pfizer G-CSF Biosimilars Product Offered
Table 98. Pfizer G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. Pfizer Main Business
Table 100. Pfizer Latest Developments
Table 101. Novartis Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 102. Novartis G-CSF Biosimilars Product Offered
Table 103. Novartis G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Roche Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 107. Roche G-CSF Biosimilars Product Offered
Table 108. Roche G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Roche Main Business
Table 110. Roche Latest Developments
Table 111. Merck & Co. Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 112. Merck & Co. G-CSF Biosimilars Product Offered
Table 113. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. Merck & Co. Main Business
Table 115. Merck & Co. Latest Developments
Table 116. Sanofi Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 117. Sanofi G-CSF Biosimilars Product Offered
Table 118. Sanofi G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. Sanofi Main Business
Table 120. Sanofi Latest Developments
Table 121. Johnson & Johnson Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 122. Johnson & Johnson G-CSF Biosimilars Product Offered
Table 123. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Johnson & Johnson Main Business
Table 125. Johnson & Johnson Latest Developments
Table 126. Gilead Science Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 127. Gilead Science G-CSF Biosimilars Product Offered
Table 128. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. Gilead Science Main Business
Table 130. Gilead Science Latest Developments
Table 131. GlaxoSmithKline Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 132. GlaxoSmithKline G-CSF Biosimilars Product Offered
Table 133. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. GlaxoSmithKline Main Business
Table 135. GlaxoSmithKline Latest Developments
Table 136. AbbVie Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 137. AbbVie G-CSF Biosimilars Product Offered
Table 138. AbbVie G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. AbbVie Main Business
Table 140. AbbVie Latest Developments
Table 141. Amgen Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 142. Amgen G-CSF Biosimilars Product Offered
Table 143. Amgen G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 144. Amgen Main Business
Table 145. Amgen Latest Developments
Table 146. AstraZeneca Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 147. AstraZeneca G-CSF Biosimilars Product Offered
Table 148. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 149. AstraZeneca Main Business
Table 150. AstraZeneca Latest Developments
Table 151. Bayer Basic Information, G-CSF Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 152. Bayer G-CSF Biosimilars Product Offered
Table 153. Bayer G-CSF Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 154. Bayer Main Business
Table 155. Bayer Latest Developments
List of Figures
Figure 1. Picture of G-CSF Biosimilars
Figure 2. G-CSF Biosimilars Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global G-CSF Biosimilars Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global G-CSF Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. G-CSF Biosimilars Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Human Growth Hormone
Figure 10. Product Picture of Erythropoietin
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Interferon
Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 15. Global G-CSF Biosimilars Sales Market Share by Type in 2021
Figure 16. Global G-CSF Biosimilars Revenue Market Share by Type (2017-2022)
Figure 17. G-CSF Biosimilars Consumed in Blood Disorders
Figure 18. Global G-CSF Biosimilars Market: Blood Disorders (2017-2022) & (K Units)
Figure 19. G-CSF Biosimilars Consumed in Oncology Diseases
Figure 20. Global G-CSF Biosimilars Market: Oncology Diseases (2017-2022) & (K Units)
Figure 21. G-CSF Biosimilars Consumed in Chronic And Autoimmune Diseases
Figure 22. Global G-CSF Biosimilars Market: Chronic And Autoimmune Diseases (2017-2022) & (K Units)
Figure 23. G-CSF Biosimilars Consumed in Growth Hormone Deficiencies
Figure 24. Global G-CSF Biosimilars Market: Growth Hormone Deficiencies (2017-2022) & (K Units)
Figure 25. Global G-CSF Biosimilars Sales Market Share by Application (2017-2022)
Figure 26. Global G-CSF Biosimilars Revenue Market Share by Application in 2021
Figure 27. G-CSF Biosimilars Revenue Market by Company in 2021 ($ Million)
Figure 28. Global G-CSF Biosimilars Revenue Market Share by Company in 2021
Figure 29. Global G-CSF Biosimilars Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global G-CSF Biosimilars Revenue Market Share by Geographic Region in 2021
Figure 31. Global G-CSF Biosimilars Sales Market Share by Region (2017-2022)
Figure 32. Global G-CSF Biosimilars Revenue Market Share by Country/Region in 2021
Figure 33. Americas G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 34. Americas G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 35. APAC G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 36. APAC G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 37. Europe G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 38. Europe G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa G-CSF Biosimilars Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa G-CSF Biosimilars Revenue 2017-2022 ($ Millions)
Figure 41. Americas G-CSF Biosimilars Sales Market Share by Country in 2021
Figure 42. Americas G-CSF Biosimilars Revenue Market Share by Country in 2021
Figure 43. United States G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC G-CSF Biosimilars Sales Market Share by Region in 2021
Figure 48. APAC G-CSF Biosimilars Revenue Market Share by Regions in 2021
Figure 49. China G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 53. India G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe G-CSF Biosimilars Sales Market Share by Country in 2021
Figure 56. Europe G-CSF Biosimilars Revenue Market Share by Country in 2021
Figure 57. Germany G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 58. France G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa G-CSF Biosimilars Sales Market Share by Country in 2021
Figure 63. Middle East & Africa G-CSF Biosimilars Revenue Market Share by Country in 2021
Figure 64. Egypt G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country G-CSF Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of G-CSF Biosimilars in 2021
Figure 70. Manufacturing Process Analysis of G-CSF Biosimilars
Figure 71. Industry Chain Structure of G-CSF Biosimilars
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
